Overview
- 180 inspections across 151 sites are on record.
- 299 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-07-17.
At a glance
Inspections
180
Sites
151
Observations
299
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lindley, Emily M. | 17 Jul 2018 | Human Drugs | View 483 → |
| Esoterix Clinical Trials Services | 27 Jun 2018 | Human Drugs | On file |
| Sara Hurvitz, MD | 8 Jun 2018 | Human Drugs | |
| Forlenza, Gregory, M.D. | 16 May 2018 | Medical Devices & Rad Health | |
| Colorado Antiviral Pharmacology Laboratory | 11 May 2018 | Human Drugs |
Sites inspected
Lindley, Emily M.Aurora, United States1 insp.
Esoterix Clinical Trials ServicesEnglewood, United States1 insp.
Sara Hurvitz, MDLos Angeles, United States1 insp.
Forlenza, Gregory, M.D.Aurora, United States1 insp.
Colorado Antiviral Pharmacology LaboratoryAurora, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Marc A Jackson5 shared
Carla R Hinz5 shared
Jonathan R Campos4 shared
Daniel P Stlaurent4 shared
Randy L Self3 shared
Matthew R Dionne3 shared
Christine I Shaw3 shared
Alan P Kurtzberg2 shared
Jennifer A Baker2 shared
Isabel Y Espinosa2 shared
Full investigator report
Get the verbatim findings behind Linda M Cherry's 299 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site